One nice little detail is the pick-up of the Chinese rights from Nova Vita. On top of the European, USA & Canada rights.
Revenue targets $5-7.5 mil PA by 2010 - and thats on top of Termilone revenues kicking in 2008-2009.
- Forums
- ASX - By Stock
- BPO
- best news bioprospect
best news bioprospect, page-5
-
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)